Coupled down-regulation of mTOR and telomerase activity during fluorouracil-induced apoptosis of hepatocarcinoma Cells
2007

5-Fluorouracil Reduces Telomerase Activity in Liver Cancer Cells

publication Evidence: moderate

Author Information

Author(s): Bu Xinxin, Jia Fengqi, Wang Weifeng, Guo Xianling, Wu Mengchao, Wei Lixin

Primary Institution: Tumor Immunology and Gene Therapy Center, Eastern Hepatobiliary Hospital, Second Military Medical University

Hypothesis

Does 5-fluorouracil down-regulate telomerase activity and mTOR signaling in hepatocellular carcinoma cells?

Conclusion

5-Fluorouracil reduces telomerase activity and promotes apoptosis in liver cancer cells by affecting both transcriptional and post-transcriptional mechanisms.

Supporting Evidence

  • 5-Fluorouracil treatment led to significant apoptosis in SMMC-7721 cells.
  • Telomerase activity and hTERT mRNA levels were significantly reduced after 5-Fu treatment.
  • 5-Fluorouracil and rapamycin together had a synergistic effect on reducing cell viability.

Takeaway

This study found that a cancer drug called 5-fluorouracil can help kill liver cancer cells by lowering a special enzyme that helps cells live longer.

Methodology

The study used cell culture, apoptosis detection via TUNEL assay, and various assays to measure telomerase activity and mTOR signaling.

Participant Demographics

Human hepatocarcinoma cell line SMMC-7721.

Statistical Information

P-Value

0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2407-7-208

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication